This technique is, however, time-consuming, labor-intensive, costly and technically challenging [10], and for this reason, surrogate markers including homeostasis model assessment for insulin resistance (HOMA-IR), the quantitative insulin sensitivity check index (QUICKI), and the fasting glucose to insulin ratio (FG-IR) have emerged to estimate IR [11]. The gene discussed is INS; the disease is Insulin resistance.